Analyst Price Targets — BHST
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 9:53 am | Sean McGowan | Roth Capital | $10.00 | $4.45 | TheFly | BioHarvest Sciences initiated with a Buy at Roth Capital |
| May 5, 2025 12:26 pm | Matthew Hewitt | Craig-Hallum | $15.00 | $6.37 | TheFly | Craig-Hallum bullish on BioHarvest Sciences, initiates with a Buy |
| December 18, 2024 12:52 pm | Anthony Vendetti | Maxim Group | $12.00 | $6.20 | TheFly | BioHarvest Sciences initiated with a Buy at Maxim |
Latest News for BHST
BioHarvest Sciences Inc. (BHST) Q4 2025 Earnings Call Transcript
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.17 per share a year ago.
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) has reported its financial results for the fourth quarter and full year 2025, highlighting revenue growth, improved margins, and continued investment in its product and contract manufacturing businesses. The company recorded full-year revenue of $34.5 million, representing a 37% increase compared to 2024.
FY2025 Revenues were $34.5 million, up 37% vs previous year. The VINIA brand has achieved the No.1 resveratrol polyphenol position in the United States Market*.
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) has reported its financial results for the fourth quarter and full year 2025, highlighting revenue growth,...
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BHST.
Senate Trading
No Senate trades found for BHST.
U.S. House Trading
No House trades found for BHST.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.